Ddfg, Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Ddfg, Inc
- $398 Billion
- Q2 2025
A detailed history of Ddfg, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ddfg, Inc holds 14,728 shares of ARWR stock, worth $566,586. This represents 0.06% of its overall portfolio holdings.
Number of Shares
14,728
Previous 14,728
-0.0%
Holding current value
$566,586
Previous $188 Million
24.02%
% of portfolio
0.06%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
324Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$603 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$597 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$408 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$245 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$201 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...